Challenges in Living Donor Liver Transplantation

Clinics in Liver Disease

Volumn 18, Issue 3, 2014, Pages 651-660

  Trotter, James F ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ABO incompatible transplant; Hepatocellular carcinoma; Living donor; Living donor liver transplantation

Indexed keywords

BLOOD GROUP ABO INCOMPATIBILITY; CANCER SURGERY; CLINICAL PROTOCOL; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; UNITED STATES; ADULT; ADVERSE EFFECTS; BLOOD GROUP ABO SYSTEM; CARCINOMA, HEPATOCELLULAR; CHILD; HOSPITAL ADMISSION; LIVER NEOPLASMS; PROCEDURES; TIME; TRANSPLANTATION; TRENDS;

BLOOD GROUP ABO SYSTEM;

ABO BLOOD-GROUP SYSTEM; ADULT; CARCINOMA, HEPATOCELLULAR; CHILD; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 84903962324     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2014.05.007     Document Type: Review

References (50)

1. Yamaoka Y., Washida M., Honda K., et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994, 57:1127-1130.
2. Wachs M.E., Bak T.E., Karrer F.M., et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998, 66:1313-1316.
3. Available at: Accessed February 1, 2014. http://optn.transplant.hrsa.gov/latestData/rptData.asp.
4. Clavien P.A., Dutkowski P., Trotter J.F. Requiem for a champion? Living donor liver transplantation. JHepatol 2009, 51:635-637.
5. Park S.J., Freise C.E., Hirose R., et al. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant 2012, 26:E359-E364.
6. Washburn K., Edwards E., Harper A., et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010, 10:1643-1648.
7. Bitterman T., Niu B., Hoteit M.A., et al. Waitlist priority for hepatocellular carcinoma beyond Milan criteria: a potentially appropriate decision without a structured approach. Am J Transplant 2014, 14:79-87.
8. Sandhu L., Sandroussi C., Guba M., et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012, 18:315-322.
9. Bhangui P., Vibert E., Majno P., et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011, 53:1570-1579.
10. Kulik L.M., Fisher R.A., Rodrigo D.R., et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant 2012, 12:2997-3007.
11. Grant R.C., Sandhu L., Dixon P.R., et al. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant 2013, 27:140-147.
12. Liang W., Wu L., Ling X., et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl 2012, 18:1226-1236.
13. Trotter J.F. Living donor liver transplantation for hepatocellular carcinoma: through the looking glass. Am J Transplant 2012, 12:2873-2874.
14. Gordon R.D., Iwatsuki S., Esquivel C.O., et al. Liver transplantation across ABO blood groups. Surgery 1986, 100:342-348.
15. Demetris A.J., Jaffe R., Tzakis A., et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988, 132:489-502.
16. Wu J., Ye S., Xu X., et al. Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis. PLoS One 2011, 6:e16521.
17. Kim J.M., Kwon C.H., Joh J.W., et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. JHepatol 2013, 59:1215-1222.
18. Soejima Y., Muto J., Matono R., et al. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. Clin Transplant 2013, 27:227-231.
19. Raut V., Mori A., Kaido T., et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation 2012, 93:99-105.
20. Uchiyama H., Mano Y., Taketomi A., et al. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange. Transplantation 2011, 92:1134-1139.
21. Tanabe M., Kawachi S., Obara H., et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest 2010, 40:943-949.
22. Ikegami T., Taketomi A., Soejima Y., et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009, 88:303-307.
23. Kawagishi N., Takeda I., Miyagi S., et al. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience. JHepatobiliary Pancreat Surg 2009, 16:468-472.
24. Usui M., Isaji S., Mizuno S., et al. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Clin Transplant 2007, 21:24-31.
25. Usuda M., Fujimori K., Koyamada N., et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 2005, 79:12-16.
26. Kawagishi N., Satomi S. ABO-incompatible living donor liver transplantation: new insights into clinical relevance. Transplantation 2008, 85:1523-1525.
27. Egawa H., Teramukai S., Haga H., et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008, 47:143-152.
28. Egawa H., Tanabe K., Fukushima N., et al. Current status of organ transplantation in Japan. Am J Transplant 2012, 12:523-530.
29. Egawa H., Teramukai S., Haga H., et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant 2014, 14:102-114.
30. Ashlagi I., Gilchrist D.S., Roth A.E., et al. Nonsimultaneous chains and dominos in kidney- paired donation-revisited. Am J Transplant 2011, 11:984-994.
31. Rees M.A., Kopke J.E., Pelletier R.P., et al. Anonsimultaneous, extended, altruistic-donor chain. NEngl J Med 2009, 360:1096-1101.
32. Chan S.C., Lo C.M., Yong B.H., et al. Paired donor interchange to avoid ABO-incompatible living donor liver transplantation. Liver Transpl 2010, 16:478-481.
33. Hwang S., Lee S.G., Moon D.B., et al. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients. Liver Transpl 2010, 16:482-490.
34. Abecassis M.M., Fisher R.A., Olthoff K.M., et al. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant 2012, 12:1208-1217.
35. Trotter J.F., Gillespie B.W., Terrault N.A., et al. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2011, 17:409-417.
36. Everson G.T., Hoefs J.C., Niemann C.U., et al. Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl 2013, 19:292-304.
37. Cheah Y.L., Simpson M.A., Pomposelli J.J., et al. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl 2013, 19:499-506.
38. Muzaale A.D., Dagher N.N., Montgomery R.A., et al. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology 2012, 142:273-280.
39. Trotter J.F., Adam R., Lo C.M., et al. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006, 12:1485-1488.
40. Brown R.S., Russo M.W., Lai M., et al. Asurvey of liver transplantation from living adult donors in the United States. NEngl J Med 2003, 348:818-825.
41. Trotter J.F., Wisniewski K.A., Terrault N.A., et al. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 2007, 46:1476-1484.
42. Trotter J.F., Hill-Callahan M.M., Gillespie B.W., et al. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation 2007, 83:1506-1508.
43. Merion R.M., Shearon T.H., Berg C.L., et al. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg 2010, 251:542-549.
44. Greenhill C. Liver transplantation: left lobe living donor liver transplantation could improve donor outcomes. Nat Rev Gastroenterol Hepatol 2012, 9:241.
45. Lo C.M. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 2003, 75:S12-S15.
46. Hashikura Y., Ichida T., Umeshita K., et al. Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009, 88:110-114.
47. Chan S.C., Fan S.T., Chok K.S., et al. Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation. Liver Transpl 2012, 18:1078-1082.
48. Soejima Y., Shirabe K., Taketomi A., et al. Left lobe living donor liver transplantation in adults. Am J Transplant 2012, 12:1877-1885.
49. Botha J.F., Langnas A.N., Campos B.D., et al. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl 2010, 16:649-657.
50. Roll G.R., Parekh J.R., Parker W.F., et al. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl 2013, 19:472-481.